Klebsiella respiratory infection community acquired Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Bacteremia in non-HIV community acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Community adquired legionella pneumophila pneumonia in elderly patients Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Common organisms causing community acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Bacterial colonization in patients with bronchiectasis Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Emerging macrolide-resistant mycoplasma pneumoniae in Thailand Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Cavitary bacterial lung infections – Predictive factors and outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Pulmonary infections with pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004
The ancient rubredoxin system: An efficient defense mechanism of pseudomonas aeruginosa during infections Source: International Congress 2014 – Immunology of respiratory infections Year: 2014
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010
Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016